Insulin and leptin revisited: Adiposity signals with overlapping physiological and intracellular signaling capabilities

Frontiers in Neuroendocrinology

Volumn 24, Issue 1, 2003, Pages 1-10

  Niswender, Kevin D ^a   Schwartz, Michael W ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR; LEPTIN; LEPTIN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE;

ARCUATE NUCLEUS; DIABETES MELLITUS; GLUCOSE HOMEOSTASIS; HORMONE ACTION; HUMAN; HYPERPHAGIA; HYPOTHALAMUS; MODEL; OBESITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0037288941     PISSN: 00913022     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3022(02)00105-X     Document Type: Review

References (76)

1. Air E.L., Benoit S.C., Blake Smith K.A., Clegg D.J., Woods S.C. Acute third ventricular administration of insulin decreases food intake in two paradigms. Pharmacol. Biochem. Behav. 72:2002;423-429.
2. Air E.L., Strowski M.Z., Benoit S.C., Conarello S.L., Salituro G.M., Guan X.M., Liu K., Woods S.C., Zhang B.B. Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity. Nat. Med. 8:2002;179-183.
3. Anderwald C., Muller G., Koca G., Furnsinn C., Waldhausl W., Roden M. Short-term leptin-dependent inhibition of hepatic gluconeogenesis is mediated by insulin receptor substrate-2. Mol. Endocrinol. 16:2002;1612-1628.
4. Bagdade J.D., Bierman E.L., Porte D. Jr. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J. Clin. Invest. 46:1967;1549-1557.
5. Banks A.S., Davis S.M., Bates S.H., Myers M.G. Jr. Activation of downstream signals by the long form of the leptin receptor. J. Biol. Chem. 275:2000;14563-14572.
6. Baura G.D., Foster D.M., Porte D. Jr., Kahn S.E., Bergman R.N., Cobelli C., Schwartz M.W. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J. Clin. Invest. 92:1993;1824-1830.
7. Benoit S.C., Air E.L., Coolen L.M., Strauss R., Jackman A., Clegg D.J., Seeley R.J., Woods S.C. The catabolic action of insulin in the brain is mediated by melanocortins. J. Neurosci. 22:2002;9048-9052.
8. Bohannon N.J., Figlewicz D.P., Corp E.S., Wilcox B.J., Porte D. Jr., Baskin D.G. Identification of binding sites for an insulin-like growth factor (IGF- I) in the median eminence of the rat brain by quantitative autoradiography. Endocrinology. 119:1986;943-945.
9. Bruning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., Orban P.C., Klein R., Krone W., Muller-Wieland D., Kahn C.R. Role of brain insulin receptor in control of body weight and reproduction. Science. 289:2000;2122-2125.
10. Burks D.J., de Mora J.F., Schubert M., Withers D.J., Myers M.G., Towery H.H., Altamuro S.L., Flint C.L., White M.F. IRS-2 pathways integrate female reproduction and energy homeostasis. Nature. 407:2000;377-382.
11. Campfield L.A., Smith F.J., Guisez Y., Devos R., Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 269:1995;546-549.
12. Challis B.G., Pritchard L.E., Creemers J.W., Delplanque J., Keogh J.M., Luan J., Wareham N.J., Yeo G.S., Bhattacharyya S., Froguel P., White A., Farooqi I.S., O'Rahilly S. A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum. Mol. Genet. 11:2002;1997-2004.
13. Chehab F.F., Lim M.E., Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat. Genet. 12:1996;318-320.
14. Chen H., Charlat O., Tartaglia L.A., Woolf E.A., Weng X., Ellis S.J., Lakey N.D., Culpepper J., Moore K.J., Breitbart R.E., Duyk G.M., Tepper R.I., Morgenstern J.P. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell. 84:1996;491-495.
15. Cohen B., Novick D., Rubinstein M. Modulation of insulin activities by leptin. Science. 274:1996;1185-1188.
16. Cohen P., Zhao C., Cai X., Montez J.M., Rohani S.C., Feinstein P., Mombaerts P., Friedman J.M. Selective deletion of leptin receptor in neurons leads to obesity. J. Clin. Invest. 108:2001;1113-1121.
17. Corp E.S., Woods S.C., Porte D. Jr., Dorsa D.M., Figlewicz D.P., Baskin D.G. Localization of 125I-insulin binding sites in the rat hypothalamus by quantitative autoradiography. Neurosci. Lett. 70:1986;17-22.
18. Cowley M.A., Smart J.L., Rubinstein M., Cerdan M.G., Diano S., Horvath T.L., Cone R.D., Low M.J. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature. 411:2001;480-484.
19. Cushman S.W., Goodyear L.J., Pilch P.F., Ralston E., Galbo H., Ploug T., Kristiansen S., Klip A. Molecular mechanisms involved in GLUT4 translocation in muscle during insulin and contraction stimulation. Adv. Exp. Med. Biol. 441:1998;63-71.
20. DeFronzo R.A. Lilly lecture 1987. The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 37:1988;667-687.
21. Dresner A., Laurent D., Marcucci M., Griffin M.E., Dufour S., Cline G.W., Slezak L.A., Andersen D.K., Hundal R.S., Rothman D.L., Petersen K.F., Shulman G.I. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J. Clin. Invest. 103:1999;253-259.
22. El-Haschimi K., Pierroz D.D., Hileman S.M., Bjorbaek C., Flier J.S. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J. Clin. Invest. 105:2000;1827-1832.
23. Farooqi I.S., Jebb S.A., Langmack G., Lawrence E., Cheetham C.H., Prentice A.M., Hughes I.A., McCamish M.A., O'Rahilly S. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N. Engl. J. Med. 341:1999;879-884.
24. Farooqi I.S., Yeo G.S., Keogh J.M., Aminian S., Jebb S.A., Butler G., Cheetham T., O'Rahilly S. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J. Clin. Invest. 106:2000;271-279.
25. Frisch R.E. Critical fatness hypothesis. Am. J. Physiol. 273:1997;E231-E232.
26. Garofalo R.S. Genetic analysis of insulin signaling in Drosophila. Trends Endocrinol. Metab. 13:2002;156-162.
27. Griffin M.E., Marcucci M.J., Cline G.W., Bell K., Barucci N., Lee D., Goodyear L.J., Kraegen E.W., White M.F., Shulman G.I. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes. 48:1999;1270-1274.
28. Halaas J.L., Gajiwala K.S., Maffei M., Cohen S.L., Chait B.T., Rabinowitz D., Lallone R.L., Burley S.K., Friedman J.M. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 269:1995;543-546.
29. Harvey J., McKay N.G., Walker K.S., Van der Kaay J., Downes C.P., Ashford M.L. Essential role of phosphoinositide 3-kinase in leptin-induced K (ATP) channel activation in the rat CRI-G1 insulinoma cell line. J. Biol. Chem. 275:2000;4660-4669.
30. Heymsfield S.B., Greenberg A.S., Fujioka K., Dixon R.M., Kushner R., Hunt T., Lubina J.A., Patane J., Self B., Hunt P., McCamish M. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. Jama. 282:1999;1568-1575.
31. Hidaka S., Yoshimatsu H., Kondou S., Oka K., Tsuruta Y., Sakino H., Itateyama E., Noguchi H., Himeno K., Okamoto K., Teshima Y., Okeda T., Sakata T. Hypoleptinemia, but not hypoinsulinemia, induces hyperphagia in streptozotocin-induced diabetic rats. J. Neurochem. 77:2001;993-1000.
32. Kaiyala K.J., Prigeon R.L., Kahn S.E., Woods S.C., Schwartz M.W. Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes. 49:2000;1525-1533.
33. Kanai F., Ito K., Todaka M., Hayashi H., Kamohara S., Ishii K., Okada T., Hazeki O., Ui M., Ebina Y. Insulin-stimulated GLUT4 translocation is relevant to the phosphorylation of IRS-1 and the activity of PI3-kinase. Biochem. Biophys. Res. Commun. 195:1993;762-768.
34. Kellerer M., Koch M., Metzinger E., Mushack J., Capp E., Haring H.U. Leptin activates PI-3 kinase in C2C12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways. Diabetologia. 40:1997;1358-1362.
35. Kennedy G.C. The role of depot fat in the hypothalamic control of food intake in the rat. Proc. Roy. Soc. Lond. 140:1953;579-592.
36. Kido Y., Nakae J., Accili D. Clinical review 125: The insulin receptor and its cellular targets. J. Clin. Endocrinol. Metab. 86:2001;972-979.
37. Kim J.K., Kim Y.J., Fillmore J.J., Chen Y., Moore I., Lee J., Yuan M., Li Z.W., Karin M., Perret P., Shoelson S.E., Shulman G.I. Prevention of fat-induced insulin resistance by salicylate. J. Clin. Invest. 108:2001;437-446.
38. Kim Y.B., Uotani S., Pierroz D.D., Flier J.S., Kahn B.B. In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: overlapping but distinct pathways from insulin. Endocrinology. 141:2000;2328-2339.
39. Lee G.H., Proenca R., Montez J.M., Carroll K.M., Darvishzadeh J.G., Lee J.I., Friedman J.M. Abnormal splicing of the leptin receptor in diabetic mice. Nature. 379:1996;632-635.
40. Levine R., Goldstein M.S., Huddlest B., Klein S.P. Action of insulin on the permeability of cells to free hexoses as studied by its effect on the distribution of galactose. Am. J. Physiol. 164:1950;70-76.
41. Lin C.Y., Higginbotham D.A., Judd R.L., White B.D. Central leptin increases insulin sensitivity in streptozotocin-induced diabetic rats. Am. J. Physiol. Endocrinol. Metab. 282:2002;E1084-E1091.
42. Marks J.L., Porte D. Jr., Stahl W.L., Baskin D.G. Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology. 127:1990;3234-3236.
43. Mokdad A.H., Bowman B.A., Ford E.S., Vinicor F., Marks J.S., Koplan J.P. The continuing epidemics of obesity and diabetes in the United States. Jama. 286:2001;1195-1200.
44. Montague C.T., Farooqi I.S., Whitehead J.P., Soos M.A., Rau H., Wareham N.J., Sewter C.P., Digby J.E., Mohammed S.N., Hurst J.A., Cheetham C.H., Earley A.R., Barnett A.H., Prins J.B., O'Rahilly S. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 387:1997;903-908.
45. Niswender K.D., Morton G.J., Stearns W.H., Rhodes C.J., Myers M.G.J., Schwartz M.W. Key enzyme in leptin-induced anorexia. Nature. 413:2001;795-796.
46. Numan S., Russell D.S. Discrete expression of insulin receptor substrate-4 mRNA in adult rat brain. Brain. Res. Mol. Brain. Res. 72:1999;97-102.
47. Obici S., Feng Z., Karkanias G., Baskin D.G., Rossetti L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat. Neurosci. 5:2002;566-572.
48. Rameh L.E., Arvidsson A., Carraway III K.L., Couvillon A.D., Rathbun G., Crompton A., VanRenterghem B., Czech M.P., Ravichandran K.S., Burakoff S.J., Wang D.S., Chen C.S., Cantley L.C. A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains. J. Biol. Chem. 272:1997;22059-22066.
49. Ranganathan S., Ciaraldi T.P., Henry R.R., Mudaliar S., Kern P.A. Lack of effect of leptin on glucose transport, lipoprotein lipase, and insulin action in adipose and muscle cells. Endocrinology. 139:1998;2509-2513.
50. Saltiel A.R., Pessin J.E. Insulin signaling pathways in time and space. Trends Cell. Biol. 12:2002;65-71.
51. Schwartz M.W., Baskin D.G., Bukowski T.R., Kuijper J.L., Foster D., Lasser G., Prunkard D.E., Porte D. Jr., Woods S.C., Seeley R.J., Weigle D.S. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes. 45:1996;531-535.
52. Schwartz M.W., Marks J.L., Sipols A.J., Baskin D.G., Woods S.C., Kahn S.E., Porte D. Jr. Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats. Endocrinology. 128:1991;2645-2647.
53. Schwartz M.W., Seeley R.J., Woods S.C., Weigle D.S., Campfield L.A., Burn P., Baskin D.G. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes. 46:1997;2119-2123.
54. Schwartz M.W., Sipols A., Kahn S.E., Lattemann D.F., Taborsky G.J., Bergman R.N., Woods S.C., Porte D. Jr. Kinetics and specificity of insulin uptake from plasma into cerebrospinal fluid. Am. J. Physiol. 259:1990;E378-E383.
55. Schwartz M.W., Sipols A.J., Marks J.L., Sanacora G., White J.D., Scheurink A., Kahn S.E., Baskin D.G., Woods S.C., Figlewicz D.P.et al. Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology. 130:1992;3608-3616.
56. Schwartz M.W., Woods S.C., Porte D. Jr., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature. 404:2000;661-671.
57. Shepherd P.R., Withers D.J., Siddle K. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling [published erratum appears in Biochem J 1998 Nov 1;335(Pt 3):711]. Biochem. J. 333:1998;471-490.
58. Shulman G.I. Cellular mechanisms of insulin resistance. J. Clin. Invest. 106:2000;171-176.
59. Sindelar D.K., Havel P.J., Seeley R.J., Wilkinson C.W., Woods S.C., Schwartz M.W. Low plasma leptin levels contribute to diabetic hyperphagia in rats. Diabetes. 48:1999;1275-1280.
60. Sipols A.J., Baskin D.G., Schwartz M.W. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression. Diabetes. 44:1995;147-151.
61. Sivitz W.I., Walsh S.A., Morgan D.A., Thomas M.J., Haynes W.G. Effects of leptin on insulin sensitivity in normal rats. Endocrinology. 138:1997;3395-3401.
62. Spanswick D., Smith M.A., Groppi V.E., Logan S.D., Ashford M.L. Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. Nature. 390:1997;521-525.
63. Spanswick D., Smith M.A., Mirshamsi S., Routh V.H., Ashford M.L. Insulin activates ATP-sensitive K+ channels in hypothalamic neurons of lean, but not obese rats. Nat. Neurosci. 3:2000;757-758.
64. Spiegelman B.M., Flier J.S. Obesity and the regulation of energy balance. Cell. 104:2001;531-543.
65. Stephens T.W., Basinski M., Bristow P.K., Bue-Valleskey J.M., Burgett S.G., Craft L., Hale J., Hoffmann J., Hsiung H.M., Kriauciunas A.et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 377:1995;530-532.
66. Strubbe J.H., Porte D. Jr., Woods S.C. Insulin responses and glucose levels in plasma and cerebrospinal fluid during fasting and refeeding in the rat. Physiol. Behav. 44:1988;205-208.
67. Szanto I., Kahn C.R. Selective interaction between leptin and insulin signaling pathways in a hepatic cell line. Proc. Natl. Acad. Sci. USA. 97:2000;2355-2360.
68. Vaisse C., Halaas J.L., Horvath C.M., Darnell J.E. Jr., Stoffel M., Friedman J.M. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat. Genet. 14:1996;95-97.
69. ′ kinase activation, and impaired atypical protein kinase C ( ζ/λ ) activation in myotubes from obese patients with impaired glucose tolerance Diabetes. 51:2002;1052-1059.
70. Wallum B.J., Taborsky G.J. Jr., Porte D. Jr., Figlewicz D.P., Jacobson L., Beard J.C., Ward W.K., Dorsa D. Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man. J. Clin. Endocrinol. Metab. 64:1987;190-194.
71. Weigle D.S., Bukowski T.R., Foster D.C., Holderman S., Kramer J.M., Lasser G., Lofton-Day C.E., Prunkard D.E., Raymond C., Kuijper J.L. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J. Clin. Invest. 96:1995;2065-2070.
72. Wolkow C.A., Kimura K.D., Lee M.S., Ruvkun G. Regulation of C. elegans life-span by insulinlike signaling in the nervous system. Science. 290:2000;147-150.
73. Woods S.C., Lotter E.C., McKay L.D., Porte D. Jr. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature. 282:1979;503-505.
74. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. [published erratum appears in Nature 1995 Mar 30;374 (6521):479] (see comments). Nature. 372:1994;425-432.
75. Zhao A.Z., Shinohara M.M., Huang D., Shimizu M., Eldar-Finkelman H., Krebs E.G., Beavo J.A., Bornfeldt K.E. Leptin induces insulin-like signaling that antagonizes cAMP elevation by glucagon in hepatocytes. J. Biol. Chem. 275:2000;11348-11354.
76. K.D. Niswender, C.D. Morrison, D.J. Clegg, R. Olson, D.G. Baskin, M.G. Myers, Jr., R.J. Seeley, M.W. Schwartz, Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia, Diabetes, in press.